Table 3 Uni- and multi-variable analysis for risk factors of invasive fungal infection.

From: Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis

Characteristics

IFI episodes (n = 40)

Non-IFI episodes (n = 512)

Univariable analysis

Multivariable analysis

P

aOR (95% CI)

P

Age, median (IQR)

58 (41–65)

54 (43–62)

0.052

1.01 (0.96–1.06)

0.768

Male

15 (37.5)

263 (51.4)

0.091

0.69 (0.28–1.70)

0.422

CCI score, median (IQR)

3 (2–5)

3 (2–4)

0.136

1.05 (0.74–1.48)

0.805

AML (vs. ALL)

28 (70.0)

365 (71.3)

0.862

1.30 (0.32–5.19)

0.714

Induction or re-induction chemotherapy (vs. consolidation)

29 (72.5)

281 (54.9)

0.031

1.79 (0.71–4.52)

0.220

No antimold prophylaxis

27 (67.5)

294 (57.4)

0.213

3.52 (1.35–9.22)

0.010

Duration of neutropenia, day, median (IQR)

21 (12–32)

15 (8–25)

0.006

1.02 (1.01–1.04)

0.001

  1. Data are shown as number (%), not otherwise specified.